Philippe Brudi, MD

Seasoned Pharmaceutical Industry leader within the Clinical Development and Medical Affairs areas.  Recognized as highly energetic with excellent communication skills and the ability to solve complex problems in a fast-paced global environment. Track record in launching gastrointestinal, cardiovascular and diabetes new treatments; internationally connected with a diverse network of experts in gastrointestinal disease, metabolic diseases, and cardiology. Proven ability to motivate cross-functional teams and work effectively with people from different cultures and all walks of life to benefit patients’ health.

Consulting mission

  • Enhancing Medical Affair’s strategic focus
  • Driving efficiency and effectiveness
  • Ensuring Launch preparedness
  • Creating meaningful metrics
  • Establishing patient centric medical practices
  • Global-regional-local Medical partnership and governance
  • Establishing Medical insights processes

Therapeutic Areas of Expertise

  • Upper Gastrointestinal diseases
  • Diabetes & DM Nephropathy
  • Atherosclerosis
  • Thrombosis
  • Heart Failure
  • Pulmonary Arterial Hypertension
  • Hypertension
  • Rare diseases: lipodystrophy, Familial Chylomicron syndrome; hypoxia inductible factor- erythropoietin gene expression regulation

Therapeutic Areas of Interest

  • NASH, Hypertriglyceridemia, CKD